Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
Expert Opinion on Pharmacotherapy
|
February 10, 2015
Smoldering multiple myeloma: to treat or not to treat
Massimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancers
|
July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities
Cirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
European Journal of Haematology
|
June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Leukemia & Lymphoma
|
May 27, 2004
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation
Pier Paolo Piccaluga, Giovanni Martinelli, Michele Malagola, et al.
European Journal of Haematology
|
October 17, 2023
Teclistamab-cqyv in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology
|
January 31, 2024
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, et al.
European Journal of Haematology
|
May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
Fortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
European Journal of Haematology
|
November 9, 2025
T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology
|
November 28, 2024
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
Caterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology
|
January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination Therapies
Antonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
Expert Opinion on Pharmacotherapy
|
February 10, 2015
Smoldering multiple myeloma: to treat or not to treat
Massimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Cancers
|
July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities
Cirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
European Journal of Haematology
|
June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Leukemia & Lymphoma
|
May 27, 2004
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation
Pier Paolo Piccaluga, Giovanni Martinelli, Michele Malagola, et al.
European Journal of Haematology
|
October 17, 2023
Teclistamab-cqyv in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology
|
January 31, 2024
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, et al.
European Journal of Haematology
|
May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
Fortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
European Journal of Haematology
|
November 9, 2025
T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology
|
November 28, 2024
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions
Caterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology
|
January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination Therapies
Antonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Page
of 12